Diseases such as Hb Barts (β-thalassemia), Duchenne muscular dystrophy (DMD), and severe combined immunodeficiency (IL2RG) have applications for these techniques as gene therapies. This evidence concerns the gene GSTM1 and Duchenne muscular dystrophy.